Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis

This post hoc exploratory analysis found no clear associations between frequently used concomitant medication combinations and disease progression in 1450 patients with IPF enrolled in phase III trials, but several combinations may require further study. http://bit.ly/2ZzyMXR

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Respir J
Autori principali: Kreuter, Michael, Lederer, David J., Cottin, Vincent, Kahn, Nicolas, Ley, Brett, Vancheri, Carlo, Weycker, Derek, Atwood, Mark, Kirchgaessler, Klaus-Uwe, Ryerson, Christopher J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: European Respiratory Society 2019
Soggetti:
Agora
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6906546/
https://ncbi.nlm.nih.gov/pubmed/31537696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01188-2019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi